There is growing evidence suggesting that DIXDC1 has carcinogenic effects in many cancers, for example, prostate cancer, glioma, non-small cell lung carcinoma and acute myeloid leukemia [33–37]. This evidence concerns the gene DIXDC1 and prostate carcinoma.